Search Results for: MARKET BRIEF The Market for


November 30, 2021

MARKET BRIEF – Navigating the Evolving Landscape of Rare Cancer Trials November 30, 2021

Rupa Doshi, PhD, and Sameena Sharif, PhD, explore the landscape of rare cancer clinical trials, from key considerations for study design and the value of biomarkers to the importance of the patient perspective and the options for speeding much-needed therapies to market.

March 3, 2015

MARKET BRIEF – Miniaturizing Healthcare – From Microelectronics to Nanobiosensing March 3, 2015

Cecilia Van Cauwenberghe, MS, Technical Insights Senior Research Analyst, Frost & Sullivan, reports that the proliferation of lower cost microfluidics-based genomics tools offering improved capabilities and allowing more access to end-users is expected to drive this technology for pharmaceutical and biomedical research throughout the next 5 years.

July 8, 2014

MARKET BRIEF – Sequestration Haunts Life Science Research Tool Market Into 2014 July 8, 2014

Christi Bird, Senior Industry Analyst, Frost & Sullivan, believes the bleakest outlook provided for the life sciences industry is one without a clear light at the end of the tunnel, and successful companies will buckle down to determine long-term strategies for beating the lackluster numbers expected from a sustained austerity policy.

November 18, 2013

MARKET BRIEF – Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs November 18, 2013

Adam M. Dion, MS, summarizes GlobalData’s recent CRO Benchmark Report and believes the dynamics of pharmaceutical outsourcing and location decisions in emerging markets are changing. Cost reduction is being augmented and will gradually be eclipsed by footprint growth as a major factor shaping decisions, and CROs are realizing that the ability to be on the ground closer to their customers is a key building block to establishing sustainable, long-term relationships with clients.

March 31, 2012

MARKET BRIEF – US Market for IV Packaging to Reach $295 Million in 2014 March 31, 2012

Bill Martineau, MBA, believes LVPs represent one of the highest value-added applications for pharmaceutical packaging. Nonetheless, demand for IV containers will expand at a lackluster pace due to trends promoting short hospital stays and less-invasive surgeries.

February 29, 2012

MARKET BRIEF – Technology Trends in the Pharmaceutical & Biopharmaceutical Industry February 29, 2012

Frost & Sullivan Analyst Cecilia E. Van Cauwenberghe believes that although the main competitive behavior around the pharmaceutical industry is based on technology differentiation and cost-based strategies, the rules governing the course of the industry are based on a complex understanding of the principal actors’ interaction.

December 31, 2011

MARKET BRIEF – Stakeholders Portrait in the Pharmaceutical Industry December 31, 2011

Frost & Sullivan Analyst Cecilia E. Van Cauwenberghe says that even though pharmaceutical and biotechnology companies, as with healthcare industry representatives, will continue to play a leading role, many players characterize the current industry landscape with many disciplines and technologies.

November 19, 2015

CELL CULTURE MARKET – 3D Cell Cultures: Next Generation & New Challenges November 19, 2015

Kevin James and Robert G. Hunter of BCC Research say significant growth within the biopharmaceuticals industry is spurring unprecedented innovation in and demand for cell culture products for the purposes of drug discovery and safety testing. While 2D cell cultures have been in laboratory use since the 1950s, the market for 3D cultures has witnessed spectacular growth throughout the past decade.